Roots Analysis

JANUARY 21, 2024

Conventional conjugation technologies used for the development of ADCs exploited the superficial lysine residues that were inherent to the native antibody structure, or the inter-chain cysteine residues, for drug-linker attachment. This trend is expected to continue in the foreseeable future.

Antibody 40

Antibody Recombinant DNA Technology Drugs Marketing 40

Cloudbyz

MARCH 6, 2024

Understanding Biologics: Biologics are a class of therapeutic agents derived from living organisms, such as cells, tissues, or proteins. Unlike traditional small molecule drugs, which are chemically synthesized, biologics are produced through complex biotechnological processes, often involving recombinant DNA technology.

Gene 71

Gene Immune Response Manufacturing Gene Therapy 71

Pharmaceutical Technology

FEBRUARY 15, 2023

Innovation S-curve for the pharmaceutical industry Gene splicing using nucleases is a key innovation area in the pharmaceutical industry Nucleases play a fundamental role in the field of recombinant DNA technology, or genetic engineering. Nucleases are enzymes that hydrolytically cleave the phosphodiester backbone of DNA.

Gene Splicing 130

Gene Splicing Gene Recombinant DNA Technology DNA 130

pharmaphorum

FEBRUARY 22, 2021

The vaccine is based around an adjuvanted recombinant protein, which will be tested in a new phase 2 study to assess the response including in older adults. But instead rivals such as BioNTech/Pfizer, AstraZeneca and Moderna have made it to market first with their vaccines.

Vaccination 89

Vaccination Vaccine Recombinant DNA Technology Trials 89